This content is only available within our institutional offering.

28 Apr 2023
Hikma Pharmaceuticals (HIK LN, 2,210p, Buy) (Company Update) - FY23 trading update: generics guidance lifted

Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
Hikma Pharmaceuticals (HIK LN, 2,210p, Buy) (Company Update) - FY23 trading update: generics guidance lifted
Hikma Pharmaceuticals Plc (HIK:LON) | 1,720 -51.6 (-0.2%) | Mkt Cap: 3,816m
- Published:
28 Apr 2023 -
Author:
Miles Dixon | Edward Sham -
Pages:
8 -